The miR-451 level was found to be decreased in human cardiac hypertrophy and subsequent sudden cardiac death, regulating cardiac hypertrophy and cardiac autophagy by targeting TSC1, showing a negative correlation with left ventricular mass and becoming a potential therapeutic target for the disease [49,50]. This evidence concerns the gene TSC1 and cardiac hypertrophy.